Cardio Flow, Inc., Announces FDA Clearance for FreedomFlow Peripheral Guidewire, plus First Commercial Case Completed in U.S.
PRESS RELEASE | FOR IMMEDIATE RELEASE | Download press release
PRESS RELEASE | FOR IMMEDIATE RELEASE | Download press release
July 15, 2021—Cardio Flow, Inc., announces that the following individuals have recently accepted positions in its newly established Sales & Marketing team:
February 2, 2021—Cardio Flow, Inc., announces completion of the enrollment phase of its FreedomFlow® Orbital Atherectomy device within its FAST II clinical trial, “Evaluation of the Cardio Flow FreedomFlow™ Orbital Circumferential Atherectomy System to Treat…